To address this deficiency, we investigated the biological and molecular changes in two HPV16-negative tongue cancer cell lines: YD8 cells bearing non-disruptive p53 mutation and YD10B cells bearing disruptive p53 mutation (26,27), which had been transfected with the HPV16 E6E7 oncogene. Here, TP53 is linked to tongue cancer.